Pricing Log in Create free account

Alamar Biosciences, Inc. (ALMR) vs AxoGen, Inc. (AXGN)

Alamar Biosciences, Inc. and AxoGen, Inc. are both Medical Devices companies. AxoGen, Inc. is the larger, with a market value of $2.9B against $1.9B — 1.6× the size. AxoGen, Inc. has the higher net margin (−12.0% vs −52.2%) and the higher return on invested capital (−5.27% vs −10.1%). Across the 16 metrics below, AxoGen, Inc. leads on 13 and Alamar Biosciences, Inc. on 3.

Valuation

Metric ALMR AXGN Medical Devices median
P/E n/m n/m 25.58
P/S 17.83 10.08 2.54
P/B 6.18 5.43 2.48
Price to free cash flow n/m 134.44 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 15.55 8.85 2.72
Earnings yield (10.19%) (1.33%) (12.82%)
Free cash flow yield (5.87%) 0.74% (8.18%)

Profitability

Metric ALMR AXGN Medical Devices median
Gross margin 58.38% 74.18% 57.76%
Operating margin (46.53%) (5.17%) (15.07%)
Net margin (52.19%) (11.96%) (14.45%)
Free cash flow margin (104.68%) 7.50% (3.88%)
Return on equity (64.46%) (10.35%) (10.35%)
Return on assets (20.81%) (8.33%) (17.26%)
Return on invested capital (10.07%) (5.27%) (5.27%)

Growth

Metric ALMR AXGN Medical Devices median
Revenue growth (TTM) — 24.32% 10.41%
EPS growth (last fiscal year) 34.77% (47.83%) 28.17%
Revenue growth, 5-year CAGR — 14.93% 15.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ALMR AXGN Medical Devices median
Debt to equity 0.00 0.04 0.04
Current ratio 9.49 12.02 2.74
Net debt to EBITDA 0.74 14.26 0.54

Dividend

Metric ALMR AXGN Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric ALMR AXGN Medical Devices median
Market cap 1.87b 2.91b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack